Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 9/20 | 0.60 |
| ▸ | PDCD1 | Q15116 | 7/20 | 0.57 |
| ▸ | CIB1 | Q99828 | 3/20 | 0.51 |
| ▸ | ACE | P12821 | 1/20 | 0.51 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.51 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.51 |
| ▸ | LDLR | P01130 | 4/20 | 0.50 |
| ▸ | PCSK9 | Q8NBP7 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17815312 | 1.00 | CD274 (0.60) | CD274PDCD1CIB1ACEACE2 | |
| SCHEMBL18257648 | 1.00 | CD274 (0.60) | CD274PDCD1CIB1ACEACE2 | |
| SCHEMBL19749615 | 0.98 | CD274 (0.63) | CD274PDCD1CIB1ACEACE2 | |
| SCHEMBL17814978 | 0.97 | CD274 (0.65) | CD274PDCD1CIB1ACEACE2 | |
| SCHEMBL18257609 | 0.97 | CD274 (0.65) | CD274PDCD1CIB1ACEACE2 | |
| SCHEMBL16128495 | 0.97 | CD274 (0.65) | CD274PDCD1CIB1ACEACE2 | |
| SCHEMBL19345117 | 0.96 | CD274 (0.66) | CD274PDCD1CIB1ACEACE2 | |
| SCHEMBL19749819 | 0.95 | CD274 (0.65) | CD274PDCD1CIB1ACEACE2 | |
| SCHEMBL19340785 | 0.95 | CD274 (0.65) | CD274PDCD1CIB1ACEACE2 | |
| SCHEMBL19749559 | 0.94 | CD274 (0.60) | CD274PDCD1CIB1ACEACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014151634-A1 | MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80(B7-1)/PD-L1 PROTEIN/PROTEIN INTERACTIONS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-09-25 | — | — | WO | disclosed |